anti-THVgp007 antibody product blogThe THVgp007 n/a (Catalog #MBS560601) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase.
ELISA: 0.5 - 0.1 ug/mL Western Blot: Recommended using at 1.0 - 0.2 ug/mL. Researchers should empirically determine the suitability of the THVgp007 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The THVgp007 n/a product has the following accession number(s) (GI #14250974) (NCBI Accession #NP_116336.1) (Uniprot Accession #Q91TV6). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Rabbits were immunized with T7 conjugated to a carrier protein. The resulting antiserum was passed over an antigen containing immunoabsorbant from which the anti-T7 was immunoaffinity purified. Purification was followed by conjugation with horseradish peroxidase (HRP).
Buffer: 50 mM HEPES - Saline with Stabilizer. Preservative: 0.002% Thimerosal
Procedure: Rabbits were immunized with T7 epitope tag conjugated to KLH. After multiple immunizations in Freund\'s adjuvant, serum was collected. Antibodies were immunoaffinity purified using the peptide conjugated to a solid-phase support and conjugated with horseradish peroxidase. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing THVgp007 are readily searchable from our website. Different antibodies against the same target such as THVgp007 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.